NB Capital ApS

What they do

NB Capital ApS is an investment firm focused on the global pharmaceutical and biotechnology sector. Founded in 2001 by experienced biotech investors and a pharmaceutical company, it invests capital in both public and private equity markets using a disciplined, risk-aware and innovation-driven approach. The firm manages approximately USD 1 billion in discretionary capital for a globally diversified base of institutional investors, sovereign wealth funds, and family offices. NB Capital emphasizes delivering clearly documented value-add investments, particularly for large institutional investors lacking internal healthcare expertise.

What they look for

NB Capital ApS invests in the global pharmaceutical and biotechnology sector across all phases of drug development and commercial enterprise, deploying capital in both public and private equity markets. Its strategy targets value-add opportunities for large institutional, sovereign wealth, and family office investors using a risk-averse, innovation-focused investment methodology.

Stage

Seed, Series A, Series B+

Sectors

Healthcare

Based

Copenhagen, DK